SCHEMBL8317135

SCHEMBL8317135

COc1cccc2c1OC(OC(=O)NCc1cccc3ccccc13)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.43
MAPT P10636 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
PKM P14618 1/20 0.43
P2RX7 Q99572 1/20 0.43
HCRTR1 O43613 3/20 0.42
HCRTR2 O43614 3/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 1/20 0.41
ATM Q13315 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319517 0.85 NFKB1 (0.52) CYP2D6MAPTCYP2C19CYP1A2CYP3A4
SCHEMBL8317168 0.85 P2RX7 (0.44) MAPTP2RX7ATMMEN1KMT2A
SCHEMBL8316604 0.78 NFKB1 (0.55) HCRTR1HCRTR2NFKB1NFKB2RELA
Hydrochloric Acid SCHEMBL7319272 0.77 NFKB1 (0.54) HCRTR1HCRTR2NFKB1NFKB2RELA
SCHEMBL9379902 0.76 MTNR1A (0.45) MAPTCYP1A2NFKB1NFKB2RELA
SCHEMBL9040773 0.75 MTNR1A (0.43) MAPTCYP1A2CYP2C9
SCHEMBL9379681 0.73 ALDH1A1 (0.46) PKMHCRTR1HCRTR2HPGDMEN1
SCHEMBL7109070 0.73 L3MBTL1 (0.45) MAPTCYP1A2L3MBTL1MEN1KMT2A
SCHEMBL7117287 0.73 L3MBTL1 (0.45) MAPTCYP1A2L3MBTL1MEN1KMT2A
SCHEMBL6753107 0.72 ATM (0.66) CYP2D6MAPTCYP2C19CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0540914-B1 2-Aminomethylchromans as active ingredients in medicaments for the treatment of diseases of the central nervous system BAYER AG (DE) 1999-06-02 EP disclosed
EP-0540914-A1 2-Aminomethylchromans as active ingredients in medicaments for the treatment of diseases of the central nervous system BAYER AG (DE) 1993-05-12 EP disclosed